Federal Register / Vol. 75, No. 21 / Tuesday, February 2, 2010 / Notices 5289 

with the Scientific Advisory Board at 

the time and in the manner permitted by 

the Board. 

DATES: The meeting will be held: 

Tuesday, March 2, 2010 from 8:30 

a.m. to 5 p.m. 

Wednesday, March 3, 2010 from 9 

a.m. to 5 p.m. 

Thursday, March 4, 2010 from 8 a.m. 

to 10 a.m. 

ADDRESSES: The meeting will be held at 

the Estancia La Jolla Hotel, 9700 N. 

Torrey Pines Road, La Jolla, CA 92037. 

FOR FURTHER INFORMATION CONTACT: Mr. 

Jonathan Bunger, SERDP Office, 901 

North Stuart Street, Suite 303, 

Arlington, VA or by telephone at (703) 

696–2126. 

Dated: January 27, 2010. 

Mitchell S. Bryman, 

Alternate OSD Federal Register Liaison 

Officer, Department of Defense. 

[FR Doc. 2010–2049 Filed 2–1–10; 8:45 am] 

BILLING CODE 5001–06–P 

DEPARTMENT OF DEFENSE 

Office of the Secretary 

Defense Health Board (DHB) Meeting 

AGENCY: Department of Defense (DoD). 

ACTION: Notice of meeting. 

SUMMARY: Pursuant to the Federal 

Advisory Committee Act of 1972 (5 

U.S.C., Appendix as amended), the 

Sunshine in the Government Act of 

1976 (5 U.S.C. 552b, as amended), and 

41 CFR 102–3.150, and in accordance 

with section 10(a)(2) of Public Law, DoD 

announces that the Defense Health 

Board (DHB or Board) will meet on 

March 1–2, 2010, to address and 

deliberate pending and new Board 

issues and provide briefings for Board 

members on topics related to ongoing 

Board business. 

DATES: The meetings will be held on 

March 1 from 7 a.m. to 5 p.m. and on 

March 2 from 7 a.m. to 2 p.m. 

The meeting is open to the public on 

March 1 from 9:15 a.m. to 12:30 p.m. 

and from 1:45 p.m. to 5 p.m. 

The Board will hold closed 

Administrative Working Meetings on 

March 1 from 9:15 a.m. to 12:30 p.m. 

and from 1:45 p.m. to 5 p.m. and on 

March 2 from 7 a.m. to 2 p.m. 

ADDRESSES: The meeting will be held at 

the Doubletree Hotel Cocoa Beach, 2080 

North Atlantic Avenue, Cocoa Beach, 

Florida 32931. 

Written statements may be mailed to 

the address under FOR FURTHER

INFORMATION CONTACT, e-mailed to 

dhb@ha.osd.mil or faxed to (703) 681– 

3317. 

FOR FURTHER INFORMATION CONTACT: 

Commander Edmond F. Feeks, 

Executive Secretary, Defense Health 

Board, Five Skyline Place, 5111 

Leesburg Pike, Suite 810, Falls Church, 

Virginia 22041–3206, (703) 681–8448, 

EXT. 1228, Fax: (703) 681–3317, 

edmond.feeks@tma.osd.mil. 

SUPPLEMENTARY INFORMATION: 

Agenda 

On March 1, 2010, the DHB will 

receive briefings on military health 

needs and priorities. The following 

Defense Health Board Subcommittees 

will present updates to the Board: 

National Capital Region Base 

Realignment and Closure, Department of 

Defense Task Force on the Prevention of 

Suicide by Members of the Armed 

Forces, Military/Occupational Health 

and Medical Surveillance, and the 

Psychological Health External Advisory 

Subcommittee. Additionally, the Board 

will receive a brief regarding Electronic 

Medical Records. The Board will also 

vote on new battlefield burn care 

guidelines in the Tactical Combat 

Casualty Care Curriculum. 

Pursuant to 5 U.S.C. 552b, as 

amended, and 41 CFR 102–3.140 

through 102–3.165 and subject 

availability of space, the Defense Health 

Board meeting from 9:15 a.m. to 12:30 

p.m. and from 1:45 p.m. to 5 p.m. on 

March 1 is open to the public. 

The Board will conduct 

administrative sessions in concert with 

the meeting on March 1, 2010, and on 

March 2, 2010 (see DATES). Pursuant to 

41 CFR 102–3.160, the administrative 

working meetings are closed to the 

public. 

Additional information, agenda 

updates, and meeting registration are 

available online at the Defense Health 

Board Web site, http://www.ha.osd.mil/ 

dhb. The public is encouraged to 

register for the meeting. 

Written Statements 

Any member of the public wishing to 

provide input to the Defense Health 

Board should submit a written 

statement in accordance with 41 CFR 

102–3.140(c) and section 10(a)(3) of the 

Federal Advisory Committee Act, and 

the procedures described in this notice. 

Written statement should be no longer 

than two type-written pages and must 

address the following detail: The issue, 

discussion, and a recommended course 

of action. Supporting documentation 

may also be included as needed to 

establish the appropriate historical 

context and to provide any necessary 

background information. 

Individuals desiring to submit a 

written statement may do so through the 

Board’s Designated Federal Officer (see 

ADDRESSES). If the written statement is 

not received at least 10 calendar days 

prior to the meeting, which is subject to 

this notice, then it may not be provided 

to or considered by the Defense Health 

Board until the next open meeting. 

The Designated Federal Officer will 

review all timely submissions with the 

Defense Health Board Chairperson, and 

ensure they are provided to members of 

the Defense Health Board before the 

meeting that is subject to this notice. 

After reviewing the written comments, 

the Chairperson and the Designated 

Federal Officer may choose to invite the 

submitter of the comments to orally 

present their issue during an open 

portion of this meeting or at a future 

meeting. 

The Designated Federal Officer, in 

consultation with the Defense Health 

Board Chairperson, may, if desired, allot 

a specific amount of time for members 

of the public to present their issues for 

review and discussion by the Defense 

Health Board. 

Special Accommodations 

If special accommodations are 

required to attend (sign language, 

wheelchair accessibility) please contact 

Ms. Lisa Jarrett at (703) 681–8448 EXT. 

1280 by February 22, 2010. 

Dated: January 28, 2010. 

Mitchell S. Bryman, 

Alternate OSD Federal Register Liaison 

Officer, Department of Defense. 

[FR Doc. 2010–2164 Filed 2–1–10; 8:45 am] 

BILLING CODE 5001–06–P 

DEPARTMENT OF DEFENSE 

Department of the Navy 

Notice of Intent To Grant Exclusive 

Patent License; Ultratrace Detection, 

LLC 

AGENCY: Department of the Navy, DoD. 

ACTION: Notice. 

SUMMARY: The Department of the Navy 

hereby gives notice of its intent to grant 

to Ultratrace Detection, LLC a revocable, 

nonassignable, exclusive license to 

practice the field of use of a Preconcentrator Device for sampling, 

collecting, analyzing, and detecting 

chemicals, warfare agents, or drugs in 

the United States, the Governmentowned inventions described in U.S. 

Patent Application No. 11/542,453 

entitled ‘‘Micro Scale Flow Through 

Sorbent Plate Collection Device’’, Navy 

Case No. 100,203 and U.S. Patent 

Application No. 12/406,756 entitled 

‘‘Actively Cooled Vapor 

mstockstill on DSKH9S0YB1PROD with NOTICES

5290 Federal Register / Vol. 75, No. 21 / Tuesday, February 2, 2010 / Notices 

Preconcentrator’’, Navy Case No. 99,832 

and any continuations, divisionals or reissues thereof. The inventions are 

jointly owned with the University of 

Louisville Research Foundation, Inc. 

and the University of Louisville will 

jointly execute the license. 

DATES: Anyone wishing to object to the 

grant of this license must file written 

objections along with supporting 

evidence, if any, not later than February 

17, 2010. 

ADDRESSES: Written objections are to be 

filed with the Naval Research 

Laboratory, Code 1004, 4555 Overlook 

Avenue, SW., Washington, DC 20375– 

5320. 

FOR FURTHER INFORMATION CONTACT: Rita 

Manak, Head, Technology Transfer 

Office, NRL Code 1004, 4555 Overlook 

Avenue, SW., Washington, DC 20375– 

5320, telephone 202–767–3083. Due to 

U.S. Postal delays, please fax 202–404– 

7920, e-mail: rita.manak@nrl.navy.mil 

or use courier delivery to expedite 

response. 

Authority: 35 U.S.C. 207, 37 CFR Part 404. 

Dated: January 26, 2010. 

A.M. Vallandingham, 

Lieutenant Commander, Judge Advocate 

General’s Corps, U.S. Navy, Federal Register 

Liaison Officer. 

[FR Doc. 2010–2119 Filed 2–1–10; 8:45 am] 

BILLING CODE 3810–FF–P 

DEPARTMENT OF DEFENSE 

Department of the Navy 

Notice of Intent To Grant Exclusive 

Patent License; Applied Minerals, Inc. 

AGENCY: Department of the Navy, DoD. 

ACTION: Notice. 

SUMMARY: The Department of the Navy 

hereby gives notice of its intent to grant 

to Applied Minerals, Inc., a revocable, 

nonassignable, exclusive license to 

practice the field of use of building 

materials which means the use of 

Halloysite Microtubules for the elution 

of any and all substances from them as 

a biocide in building materials 

including but not limited to, grouts, 

cements, parging materials, stuccos, and 

mortars; and wallboards, and cellulosebased materials such as particleboard, 

paneling, medium density fiberboard 

(MDF) paneling, plywood, lumber, 

chipboard, and ceiling tile; and caulks, 

sealants and adhesives; and high 

pressure laminates, wall, counter top 

and floor coverings or components 

thereof; and ceramics, cultured marbles, 

and tiles; and non-cellulose (i.e. 

polymer) based wallpapers, paneling, 

and other wall, counter top, and floor 

coverings or components; and 

insulations; and the field of use of paint 

which means the use of Halloysite 

Microtubules for the elution of any and 

all substances in paints, sealers, fillers, 

varnishes, shellac, polyurethane 

coatings, and any and all ‘‘paint-like’’ 

coatings applied in liquid form to any 

and all surfaces for the beautification or 

protection of surfaces in structures or 

components thereof, including but not 

limited to, buildings, marine structures 

(including boats), furniture and other 

normally ‘‘painted’’ materials in the 

United States, the Government-owned 

inventions described in U.S. Patent No. 

5,492,696: Controlled Release 

Microstructures, Navy Case No. 

76,896.//U.S. Patent No. 5,651,976: 

Controlled Release of Active Agents 

Using Inorganic Tubules, Navy Case No. 

76,652.//U.S. Patent No. 5,705,191: 

Sustained Delivery of Active 

Compounds from Tubules with Rational 

Control, Navy Case No. 77,037.//U.S. 

Patent No. 6,280,759: Method of 

Controlled Release and Controlled 

Release Microstructures, Navy Case No. 

78,215 and any continuations, 

divisionals or re-issues thereof. 

DATES: Anyone wishing to object to the 

grant of this license must file written 

objections along with supporting 

evidence, if any, not later than February 

17, 2010. 

ADDRESSES: Written objections are to be 

filed with the Naval Research 

Laboratory, Code 1004, 4555 Overlook 

Avenue, SW., Washington, DC 20375– 

5320. 

FOR FURTHER INFORMATION CONTACT: Rita 

Manak, Head, Technology Transfer 

Office, NRL Code 1004, 4555 Overlook 

Avenue, SW., Washington, DC 20375– 

5320, telephone 202–767–3083. Due to 

U.S. Postal delays, please fax 202–404– 

7920, e-mail: rita.manak@nrl.navy.mil 

or use courier delivery to expedite 

response. 

(Authority: 35 U.S.C. 207, 37 CFR part 404) 

Dated: January 22, 2010. 

A.M. Vallandingham, 

Lieutenant Commander, Judge Advocate 

General’s Corps, U.S. Navy, Federal Register 

Liaison Officer. 

[FR Doc. 2010–2120 Filed 2–1–10; 8:45 am] 

BILLING CODE 3810–FF–P 

DEPARTMENT OF DEFENSE 

Department of the Navy 

Notice of the Record of Decision for 

the United States Marine Corps Grow 

the Force at Marine Corps Base Camp 

Lejeune, Marine Corps Air Station New 

River, and Marine Corps Air Station 

Cherry Point, NC 

AGENCY: Department of the Navy, DOD. 

ACTION: Notice of Record of Decision. 

SUMMARY: Pursuant to Section 102(2)(c) 

of the National Environmental Policy 

Act (NEPA) of 1969, 42 United States 

Code (U.S.C.) Section 4332(2)(c), the 

regulations of the Council on 

Environmental Quality (CEQ) for 

Implementing the Procedural Provisions 

of NEPA (40 Code of Federal 

Regulations [CFR] parts 1500–1508), the 

Department of the Navy NEPA 

regulations (32 CFR part 775), and the 

Marine Corps Environmental 

Compliance and Protection Manual, 

which is Marine Corps Order P5090.2A 

w/change 2 (MCO P5090.2A), the 

Department of the Navy (DON) 

announces its decision to implement the 

permanent incremental increase in 

personnel at Marine Corps Base (MCB) 

Camp Lejeune, Marine Corps Air Station 

(MCAS) New River, and MCAS Cherry 

Point, North Carolina. 

More specifically, this action 

includes: (1) New infrastructure 

construction (e.g. buildings, roads, 

utility lines); (2) demolition and/or 

upgrades to existing infrastructure; and 

(3) relocating existing units and 

personnel to consolidate and better 

support the combat missions. 

Implementation of this action will be 

accomplished as set out in the Preferred 

Alternative and described in the Final 

Environmental Impact Statement (Final 

EIS) of December 11, 2009. 

SUPPLEMENTARY INFORMATION: The 

complete text of the Record of Decision 

is available for public viewing on the 

project Web site at http:// 

www.growtheforcenc.com along with 

copies of the Final EIS and supporting 

documents. For further information, 

contact Grow the Force in North 

Carolina EIS Project Manager, Naval 

Facilities Engineering Command, MidAtlantic, Building C Room 3012, 6505 

Hampton Blvd., Norfolk, VA 23508– 

1278. Telephone: 757–322–4942. 

Dated: January 22, 2010. 

A.M. Vallandingham, 

Lieutenant Commander, Judge Advocate 

General’s Corps, U.S. Navy, Federal Register 

Liaison Officer. 

[FR Doc. 2010–2118 Filed 2–1–10; 8:45 am] 

BILLING CODE 3810–FF–P 

mstockstill on DSKH9S0YB1PROD with NOTICES